Laser and electromagnetic combo targets back pain without drugs

NCT ID NCT07700433

First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time

Summary

This study tests whether two devices used together can reduce back pain. The BTL-043 device delivers near-infrared laser energy, and the BTL-899 device uses electromagnetic energy. Sixty adults with back pain will receive four treatment sessions and be followed for three months to measure changes in pain and daily function.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a combination of two devices: BTL-043 (EMVITAL), which delivers near-infrared laser energy, and BTL-899 (EMSCULPT NEO), which delivers electromagnetic energy
What this could lead to
If successful, this could offer a non-invasive, drug-free option for reducing back pain and improving daily function.
What could go wrong
This is a small, early-stage study with no control group, so results may not be conclusive. The devices are already used for other purposes, but their effectiveness for back pain is not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BACK PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Back Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Active Edge Health

    Columbus, Ohio, 43215, United States

  • Novaré Medical and Wellness

    Fort Myers, Florida, 33908, United States

  • Pinnacle Integrative Orthopedics

    Wichita Falls, Texas, 76301, United States

  • Royal Spine Surgery

    Scottsdale, Arizona, 85260, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.